Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma

BACKGROUND: AKT is commonly overexpressed in tumours and plays an important role in the metabolic reprogramming of cancer. We have used magnetic resonance spectroscopy (MRS) to assess whether inhibition of AKT signalling would result in metabolic changes that could potentially be used as biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Saffar, Nada M. S., Troy, Helen, Wong Te Fong, Anne-Christine, Paravati, Roberta, Jackson, L. Elizabeth, Gowan, Sharon, Boult, Jessica K. R., Robinson, Simon P., Eccles, Suzanne A., Yap, Timothy A., Leach, Martin O., Chung, Yuen-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219501/
https://www.ncbi.nlm.nih.gov/pubmed/30377337
http://dx.doi.org/10.1038/s41416-018-0242-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219501/
https://www.ncbi.nlm.nih.gov/pubmed/30377337
http://dx.doi.org/10.1038/s41416-018-0242-3

Ejemplares similares